Novartis Investigative Site

Miyagi 980-8574

0 studies enrolling now · 3 studies all time

What they study most

Lymphoma, Follicular, Non-Hodgkin's Lymphoma, Ovarian Cancer

Studies at this site

• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early